Artivion | CRY - 销售和管理费用

股票价格

37.84

每天变化

1.10 2.99%

每月一次

3.19%

每年

67.95%

Q2 预测

36.60

金融业

USD

USD 884.8M

现金及等价物

USD 64.91M

USD 42.85M

USD 358.08M

USD 101.56M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 448.23M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 217.81M

USD 1.54B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 92.43M

贸易债权人

USD 16.04M

应收帐款人

USD 103.68M

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Accuray	USD 127.32M		500.16M	2025-09
AngioDynamics	USD 36.57M		3.79M	2025-09
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 78.34M		109K	2025-12
Baxter International	USD 761M		53M	2025-12
Becton, Dickinson and Co.	USD 1.39B		27M	2025-12
Boston Scientific	USD 1.83B		93M	2025-12
Edwards Lifesciences	USD 602.9M		88.3M	2025-12
Inogen	USD 43.77M		510K	2024-06
Integra LifeSciences	USD 156.45M		12.6M	2025-12
J&J	USD 6.03B		719M	2026-03
Mesa Laboratories	USD 27.31M		380K	2024-09
Orthofix International	USD 130.35M		11.31M	2025-12
Pfizer	USD 4.08B		894M	2025-12
ResMed	USD 278.4M		19.2M	2025-12
Stryker	USD 2.14B		150M	2025-12
Surmodics	USD 11.4M		3.18M	2025-06
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 222.37M		59.4M	2025-12
Terumo	JPY 105.26B		7.38B	2025-12
Trinity Biotech	USD 6.19M		2.18M	2025-09